Team:Wageningen UR
From 2012.igem.org
TSlijkhuis (Talk | contribs) |
TSlijkhuis (Talk | contribs) |
||
Line 9: | Line 9: | ||
<div id="projectVideo"> | <div id="projectVideo"> | ||
<div id="projectVideoPlayer"></div> | <div id="projectVideoPlayer"></div> | ||
+ | <a class="projectIntroButton" href="javascript:" title="Play Intro Movie">> Play Intro Movie</a> | ||
</div> | </div> | ||
<div id="toProjectOverview"> | <div id="toProjectOverview"> | ||
- | <a href="/Team:Wageningen_UR/Project" title="Project Overview">> To Project Overview</a> | + | <a class="projectIntroButton" href="/Team:Wageningen_UR/Project" title="Project Overview">> To Project Overview</a> |
</div> | </div> | ||
Revision as of 13:35, 21 September 2012
Abstract
A standardized tool for site specific drug delivery using Virus-Like Particles
Medicines are generally active in a non-site-specific fashion, affecting the whole patient, including healthy tissue. Therefore, we attempt to specifically target diseased areas by packaging medicines inside Virus-Like Particles (VLPs). VLPs are not infectious, as they are built solely from viral coat proteins. We designed a modular Plug and Apply system that enables modifications to these coat proteins. The system facilitates the linkage of numerous ligands to the coat protein, thereby creating site-specific carriers. After expression of coat protein genes in Escherichia coli the VLPs were assembled in vitro, yielding modified Virus-Like Particles. Medicines can be packed using the Plug and Apply system or simply by addition during VLP assembly. Concluding, VLPs can be used as universal carriers for site-specific drug delivery, allowing customization to a variety of diseases while decreasing side effects for patients during treatment.
The Constructor
An application that assists you in creating your cloning strategies for your iGEM project.